������Ƶ

Robert Webster and Charleson Bell will lead regional Research Evaluation and Commercialization Hub to propel inclusive innovation and catalyze a medical innovation economy. Read More

Widespread trust in vaccines often leads to higher vaccination rates, but vaccine shortages can deter even those with confidence in vaccines. Furthermore, while vaccine mandates can create an appearance of universal vaccination, people may remain hesitant, resulting in lower compliance than anticipated. Read More

The grant will prepare genetic counselors to contribute more fully to the advancement of personalized medicine. Nancy Cox, Ph.D., who directs the Vanderbilt Genetics Institute and the Division of Genetic Medicine, and Martha Dudek, M.S. CGC, director of the Vanderbilt Master of Genetic Counseling program, will serve as co-principal investigators.

A Vanderbilt study found that a molecular signature that predicts aggressive thyroid cancer could help guide treatment approaches for patients.

A new study by Vanderbilt researchers provides a remarkably detailed view of the earliest events leading to the development of cancer, and of potential new ways to prevent it.

Vanderbilt researchers found reduced net flow of cerebrospinal fluid in Huntington’s disease, which could contribute to mutant protein retention and altered responsiveness to medications delivered via the spinal cord.

Vanderbilt researchers have uncovered a potential new way to help curb the rapidly rising worldwide prevalence of metabolic disorders, including obesity and diabetes.

The Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation has awarded a three-year grant to support research led by Houra Merrikh, PhD, professor of Biochemistry, and Ben Ho Park, MD, PhD, the Benjamin F. Byrd Jr. Professor of Oncology and director of Vanderbilt-Ingram Cancer Center, to create an anti-evolution drug to reduce the capacity of cancer cells to develop resistance.

Vanderbilt researchers have demonstrated that a cluster of microRNAs — small pieces of RNA that regulate gene expression — work in a type of immune cells called macrophages to help protect against metabolic defects in obesity.

Being named a fellow is one of the highest distinctions the nursing profession bestows, as it recognizes the impact an individual has made on health, health care and nursing. Professors Jennifer Kim and Rolanda Johnson and Assistant Professors Leanne Boehm and Lori Schirle will be inducted into the academy on Oct. 7.

Researchers at Vanderbilt University Medical Center and the Nashville Veterans Affairs Medical Center have “cracked” the genomic code for sepsis in the lungs and kidneys.

Kendra M. Faucett, DNP, BS’00, CNM, APRN, CNE, FACNM, will become academic director for the Vanderbilt University School of Nursing’s Nurse-Midwifery specialty on September 18. She comes to Nashville from her role as an assistant professor and course coordinator at Frontier Nursing University.  “I am thrilled to be joining the No. 1 midwifery program in the country,” Faucett said. “Vanderbilt has an outstanding reputation,...

10 basic sciences graduate students were recognized for their high academic and scientific achievement and for the originality, significance, and rigor of their dissertation research with the Dean’s Award for Exceptional Achievement in Graduate Studies.

Four Vanderbilt graduate students, faculty advisers named to Howard Hughes Medical Institute Gilliam Fellows Program for their leadership in science and commitment to advancing equity and inclusion in science. Read More

Vanderbilt researchers found that that T cells become “exhausted” within hours of encountering a tumor, challenging existing ideas about how T cells become dysfunctional.

The Tennessee Action Coalition has included a School of Nursing faculty member and a Monroe Carell Jr. Children’s Hospital at Vanderbilt nurse in its 2023 cohort of Tennessee Rising Star Nurse Leaders. VUSN Assistant Professor Monika Schmidt Do, DNP, FACC, and clinical staff leader Cory Smeltzer, RN, were among 25 young Tennessee nurse leaders named rising stars.

Researchers at Vanderbilt University Medical Center have received a four-year, $28 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases to study the relationship between COVID-19 and diabetes.

Nancy Cox, PhD, director of the Vanderbilt Genetics Institute, is the recipient of the 2023 ASHG Leadership Award from the American Society of Human Genetics.

Researchers at Vanderbilt University Medical Center and the University of Cambridge have developed a method of or predicting gene expression in hard-to-access tissues like the brain from more accessible tissues, including whole blood.

Vanderbilt's Andreana Holowatyj, PhD, MSCI, has received the National Cancer Institute’s Method to Extend Research in Time Award to support her ongoing investigation into how early-onset colorectal cancer and its treatments impact reproductive health.